APA

Trappe R., Oertel S., Leblond V., Mollee P., Sender M., Reinke P., Neuhaus R., Lehmkuhl H., Horst H. A., Salles G., Morschhauser F., Jaccard A., Lamy T., Leithäuser M., Zimmermann H., Anagnostopoulos I., Raphael M., Riess H. & Choquet S. (20120320). Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. : The Lancet. Oncology.

Chicago

Trappe Ralf, Oertel Stephan, Leblond Veronique, Mollee Peter, Sender Monica, Reinke Petra, Neuhaus Ruth, Lehmkuhl Hans, Horst Heinz August, Salles Gilles, Morschhauser Franck, Jaccard Arnaud, Lamy Thierry, Leithäuser Malte, Zimmermann Heiner, Anagnostopoulos Ioannis, Raphael Martine, Riess Hanno and Choquet Sylvain. 20120320. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. : The Lancet. Oncology.

Harvard

Trappe R., Oertel S., Leblond V., Mollee P., Sender M., Reinke P., Neuhaus R., Lehmkuhl H., Horst H. A., Salles G., Morschhauser F., Jaccard A., Lamy T., Leithäuser M., Zimmermann H., Anagnostopoulos I., Raphael M., Riess H. and Choquet S. (20120320). Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. : The Lancet. Oncology.

MLA

Trappe Ralf, Oertel Stephan, Leblond Veronique, Mollee Peter, Sender Monica, Reinke Petra, Neuhaus Ruth, Lehmkuhl Hans, Horst Heinz August, Salles Gilles, Morschhauser Franck, Jaccard Arnaud, Lamy Thierry, Leithäuser Malte, Zimmermann Heiner, Anagnostopoulos Ioannis, Raphael Martine, Riess Hanno and Choquet Sylvain. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. : The Lancet. Oncology. 20120320.